Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Galle

Showing results (211-220 of 709) with videos related to

Pageof 71
Sort By:
Digestive Diseases and Sciences|December 5, 2019
Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in GermanyChristian Labenz, Yvonne Huber, Maurice Michel, et al.
Oncogene|August 30, 2001
Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesisS Kanzler, E Meyer, A W Lohse, et al.
Immunology Letters|May 26, 2004
HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cellsMarcus Schuchmann, Frank Hermann, Johannes Herkel, et al.
World Journal of Gastroenterology|February 6, 2009
Hepatocellular carcinoma in patients with autoimmune hepatitisAndreas Teufel, Arndt Weinmann, Catherine Centner, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2020
Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based studyChristian Labenz, Marcus-Alexander Wörns, Charles C Adarkwah, et al.
Oncogene|January 1, 1994
p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutationM Volkmann, W J Hofmann, M Müller, et al.
BMC Cancer|July 19, 2006
Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case reportMartin F Sprinzl, Carl C Schimanski, Markus Moehler, et al.
Free Radical Biology & Medicine|March 13, 2012
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytesJörn M Schattenberg, Marcus A Wörns, Tim Zimmermann, et al.
Hepatology Communications|September 14, 2020
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and DepressionChristian Labenz, Yvonne Huber, Maurice Michel, et al.
European Journal of Gastroenterology & Hepatology|August 16, 2020
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysisChristian Labenz, Gerrit Toenges, Marcus-Alexander Wörns, et al.
Pageof 71

Showing results (211-220 of 709) with videos related to

Sort By:
Pageof 71
Digestive Diseases and Sciences|December 5, 2019
Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in GermanyChristian Labenz, Yvonne Huber, Maurice Michel, et al.
Oncogene|August 30, 2001
Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesisS Kanzler, E Meyer, A W Lohse, et al.
Immunology Letters|May 26, 2004
HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cellsMarcus Schuchmann, Frank Hermann, Johannes Herkel, et al.
World Journal of Gastroenterology|February 6, 2009
Hepatocellular carcinoma in patients with autoimmune hepatitisAndreas Teufel, Arndt Weinmann, Catherine Centner, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2020
Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based studyChristian Labenz, Marcus-Alexander Wörns, Charles C Adarkwah, et al.
Oncogene|January 1, 1994
p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutationM Volkmann, W J Hofmann, M Müller, et al.
BMC Cancer|July 19, 2006
Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case reportMartin F Sprinzl, Carl C Schimanski, Markus Moehler, et al.
Free Radical Biology & Medicine|March 13, 2012
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytesJörn M Schattenberg, Marcus A Wörns, Tim Zimmermann, et al.
Hepatology Communications|September 14, 2020
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and DepressionChristian Labenz, Yvonne Huber, Maurice Michel, et al.
European Journal of Gastroenterology & Hepatology|August 16, 2020
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysisChristian Labenz, Gerrit Toenges, Marcus-Alexander Wörns, et al.
Pageof 71